Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03171987Phase 4Completed
Phase 4, randomised, single-blind trial of lidocaine 10% oropharyngeal spray in acute low back pain (2 arms), sponsored by Taipei Medical University Hospital. Primary endpoint: Numeric Rating Scale at 28 days. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03171987.